Overview and Scope
A primary care point-of-care (POC) diagnostic is a medical test or assessment performed conveniently and quickly within a primary care setting, such as a doctor’s office or a clinic, without requiring specialized equipment or extensive laboratory processing. These diagnostics are designed to provide rapid results, allowing healthcare providers to make timely decisions about patient care during the initial consultation.
Sizing and Forecast
The primary care POC diagnostics market size has grown strongly in recent years. It will grow from $15.32 billion in 2023 to $16.46 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to the increasing prevalence of chronic diseases, shift towards personalized medicine, growing healthcare expenditure, rise in supportive regulatory frameworks and expedited approval processes, and growing emphasis on early disease detection and prevention strategies.
The primary care POC diagnostics market size is expected to see strong growth in the next few years. It will grow to $22.19 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to the emergence of infectious disease outbreaks, expanding applications in non-communicable diseases, increasing adoption in home healthcare settings, growth in precision medicine initiatives, rising healthcare infrastructure investments, increasing disease burden, and growing awareness of the importance of early disease detection. Major trends in the forecast period include the integration of artificial intelligence (AI) and machine learning algorithms, advancements in molecular diagnostics technologies, miniaturization and portability of POC diagnostic devices, integration of smart devices, and usage of multiplexing and panel testing in POC diagnostics.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report
Segmentation & Regional Insights
The primary care poc diagnostics market covered in this report is segmented –
1) By Product: Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products
2) By Prescription: Prescription Based, Over-The-Counter (OTC) Testing
3) By End-Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses
North America was the largest region in the primary care POC diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp
Major Driver Impacting Market Growth
The rise in the prevalence of infectious diseases is expected to propel the growth of the primary care POC diagnostics market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. These diseases spread from one person to another directly or indirectly through contact with contaminated surfaces, air, water, or vectors such as insects. The prevalence of infectious diseases is due to poor environmental conditions, urbanization, antimicrobial resistance, and inadequate vaccination coverage. Primary care POC diagnostics are integral tools for combating the prevalence of infectious diseases by facilitating early detection, timely treatment, and effective disease control measures in diverse healthcare settings. For instance, in October 2023, according to a report published by the UK Health Security Agency, a UK-based government agency responsible for overseeing and managing public health security, the number of HIV diagnoses in England rose by 22% from 3,118 in 2021 to 3,805 in 2022. Furthermore, in November 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, around 10.6 million cases of tuberculosis (TB) occurred globally in 2022, affecting 5.8 million men, 3.5 million women, and 1.3 million children. Therefore, the rise in the prevalence of infectious diseases is driving the primary care POC diagnostics market.
Key Industry Players
Major companies operating in the primary care POC diagnostics market are Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc, DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.
The primary care poc diagnostics market report table of contents includes:
1. Executive Summary
2. Primary Care POC Diagnostics Market Characteristics
3. Primary Care POC Diagnostics Market Trends And Strategies
4. Primary Care POC Diagnostics Market – Macro Economic Scenario
5. Global Primary Care POC Diagnostics Market Size and Growth
.
.
.
31. Global Primary Care POC Diagnostics Market Competitive Benchmarking
32. Global Primary Care POC Diagnostics Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Primary Care POC Diagnostics Market
34. Primary Care POC Diagnostics Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
